Publicaciones en colaboración con investigadores/as de Karolinska Institute (21)

2019

  1. Galanin (1–15)-fluoxetine interaction in the novel object recognition test. Involvement of 5-HT1A receptors in the prefrontal cortex of the rats

    Neuropharmacology, Vol. 155, pp. 104-112

2014

  1. Galanin receptor/neuropeptide y receptor interactions in the central nervous system

    Current Protein and Peptide Science, Vol. 15, Núm. 7, pp. 666-672

2007

  1. Region specific galanin receptor/neuropeptide Y Y1 receptor interactions in the tel- and diencephalon of the rat. Relevance for food consumption

    Neuropharmacology, Vol. 52, Núm. 2, pp. 684-692

2005

  1. Intracisternal galanin/angiotensin II interactions in central cardiovascular control

    Regulatory Peptides, Vol. 127, Núm. 1-3, pp. 133-140

  2. Role of galanin and galanin(1-15) on central cardiovascular control

    Neuropeptides

2003

  1. Angiotensin II modulates the cardiovascular responses to microinjection of NPY Y1 and NPY Y2 receptor agonists into the nucleus tractus solitarii of the rat

    Brain Research, Vol. 983, Núm. 1-2, pp. 193-200

2002

  1. Propranolol blocks the tachycardia induced by galanin (1-15) but not by galanin (1-29)

    Regulatory Peptides, Vol. 107, Núm. 1-3, pp. 29-36

2001

  1. Central galanin and N-terminal galanin fragment induce c-Fos immunoreactivity in the medulla oblongata of the anesthetized rat

    Peptides, Vol. 22, Núm. 9, pp. 1501-1509

2000

  1. The galanin receptor antagonist M40 blocks the central cardiovascular actions of the galanin N-terminal fragment (1-15)

    European Journal of Pharmacology, Vol. 399, Núm. 2-3, pp. 197-203

1998

  1. Galanin and NH2-Terminal galanin fragments in central cardiovascular regulation

    Annals of the New York Academy of Sciences

1994

  1. Adrenalectomy increases the number of substance P and somatostatin immunoreactive nerve cells in the rat lumbar dorsal root ganglia

    Brain Research, Vol. 640, Núm. 1-2, pp. 352-356

  2. Subpopulations of primary sensory neurons show coexistence of neuropeptides and glucocorticoid receptors in the rat spinal and trigeminal ganglia

    Brain Research, Vol. 636, Núm. 2, pp. 338-342

1993

  1. Coexistence of c-Fos and glucocorticoid receptor immunoreactivities in the CRF immunoreactive neurons of the paraventricular hypothalamic nucleus of the rat after acute immobilization stress

    Neuroscience Letters, Vol. 149, Núm. 2, pp. 149-152

  2. Induction of c-fos immunoreactivity in tyrosine hydroxylase and phenylethanolamine-N-methyltransferase immunoreactive neurons of the medulla oblongata of the rat after phosphate-buffered saline load in the urethane-anaesthetized rat

    Brain Research, Vol. 602, Núm. 2, pp. 342-349

1992

  1. Distribution of somatostatin-28 (1-12) in the cat brainstem: an immunocytochemical study

    Neuropeptides, Vol. 21, Núm. 1, pp. 1-11

  2. Steroidal regulation of coexisting neuronal messengers: Focus on double and triple immunolabeling procedures and on indirect evaluation of coexistence

    Neuroprotocols, Vol. 1, Núm. 1, pp. 77-86

1991

  1. Distribution of neurotensin-like immunoreactive cell bodies and fibers in the brainstem of the adult male cat

    Peptides, Vol. 12, Núm. 6, pp. 1201-1209

  2. Neurotensin-like immunoreactivity in the diencephalon of the adult male cat

    Peptides, Vol. 12, Núm. 2, pp. 257-264

  3. Somatostatin-28 (1-12)-like immunoreactivity in the cat diencephalon

    Neuropeptides, Vol. 19, Núm. 2, pp. 107-117

1990

  1. Evidence for the existence of angiotensin II like immunoreactivity in subpopulations of tyrosine hydroxylase immunoreactive neurons in the A1 and C1 area of the ventral medulla of the male rat

    Neuroscience Letters, Vol. 114, Núm. 2, pp. 160-166